The National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, awarded a $16,000 purchase order to Cellx, Inc., a small business, on September 29, 2025, for pharmaceutics formulation, chemistry manufacturing and controls (CMC) consulting services supporting drug discovery and development programs. The contract, which runs through September 28, 2028, provides specialized subject matter expert consultation for small molecules and biologics development, with...
The National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, awarded a $54,000.00 labor-hour purchase order contract to RPK Associates, LLC, a small business, for pharmaceutics formulation and chemistry manufacturing and controls (CMC) consulting services for small molecules and/or biologics. The contract has a base period from September 20, 2025, through September 19, 2026, with optional hours up to 800 total hours per consultant annually. The services...
The U.S. National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services' National Institutes of Health, awarded a $19,600.00 Purchase Order contract to Lin Jiunn, a small business located in Ambler, Pennsylvania. The contract is for a Subject Matter Expert Consultant in Drug Metabolism Pharmacokinetics (DMPK) to support NIDA's NIH Blueprint Neurotherapeutics Network program. The contract has a one-year base period with an estimated minimum of 20 annual hours and a...
The National Institute on Drug Abuse, a component of the Department of Health and Human Services' National Institutes of Health, awarded a $630,035 firm fixed price purchase order to Science Management Associates of Bethesda, Maryland. The contract calls for meeting consultation services to support NIDA's executive coaching, consulting, and organizational development initiatives. Specifically, Science Management Associates will provide coaching, meeting facilitation, training development, and...
<p>This is a $18,963.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to NINDS PHARMAC LLC for medicinal chemistry consulting services. The contract has a Total Small Business set-aside designation. The contract was awarded on January 12, 2017 and has an ultimate completion date of January 12, 2022. The place of performance is Bethesda, Maryland.</p>
The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a definitive contract to Lowery Creek Consulting, LLC on February 24, 2017, with an ultimate completion date of May 22, 2022. The contract, valued at $85,758.00 on a firm fixed-price basis, was executed without a set-aside designation. The work was performed at the NIDA facility in Bethesda, Maryland, and involved CMC Consulting Services under the NINDS BPN/Lowery Creek program. The primary purpose of this contract...
The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, awarded a $120,969.12 firm-fixed-price delivery order contract to 22nd Century Technologies, Inc., a minority-owned small business. The contract is part of the Scientific, Operations, and Administrative Resources (SOAR) multiple-award indefinite-delivery/indefinite-quantity (IDIQ) contract valued at $3.6 billion, which provides a wide range of information technology products,...
The U.S. National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, has awarded a $136,232.50 firm-fixed-price delivery order to Synectics For Management Decisions, Inc., a woman-owned small business. This delivery order was issued under the Chief Information Officer - Solutions and Partners 3, Small Business (CIO-SP3 SB) government-wide acquisition contract. The contract will provide web developer services to support NIDA's research programs...
This is a $4,026,071.62 cost-plus-fixed-fee contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health, to SD Solutions LLC, an 8(a) small disadvantaged business based in Rockville, Maryland. The contract is for the NIDA Clinical Trials Research Coordination Center, which will provide logistical and operational support services for NIDA's National Drug Abuse Treatment Clinical Trials Network. This includes coordinating meetings,...
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health under the Department of Health and Human Services, awarded a $11,250 purchase order to Franklin Adme Consult, LLC on September 18, 2025, for subject matter expert consulting services in Drug Metabolism Pharmacokinetics (DMPK). This total small business set-aside contract is structured as a labor hour engagement with a completion date of September 17, 2026, and will support the NIH Blueprint Neurotherapeutics...
The National Institute on Drug Abuse awarded a $79,569.86 firm fixed-price purchase order to Salient Science & Technology LLC for pharmaceutical business development consulting services. The contract, designated as a Total Small Business set-aside, was awarded on February 27, 2017, with an ultimate completion date of April 14, 2022. Work is being performed in Bethesda, Maryland, and the engagement focuses on business development consulting support for the institute's pharmaceutical initiatives.
This consulting contract supports NIDA's mission to advance science on drug abuse and addiction through high-quality research and evidence-based interventions. The business development consulting services provided by Salient Science & Technology LLC contribute to the institute's strategic efforts in identifying and evaluating pharmaceutical partnerships and opportunities that align with its research and public health objectives.